RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Brenda Y. Hernandez to Breast Neoplasms

This is a "connection" page, showing publications Brenda Y. Hernandez has written about Breast Neoplasms.
Connection Strength

2.427
  1. Taparra K, Fukui J, Killeen J, Sumida K, Loo LWM, Hernandez BY. Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawai'i. JAMA Netw Open. 2021 10 01; 4(10):e2128977.
    View in: PubMed
    Score: 0.324
  2. Maskarinec G, Ju D, Shvetsov YB, Horio D, Chan O, Loo LWM, Hernandez BY. Breast tumor tissue inflammation but not lobular involution is associated with survival among breast cancer patients in the Multiethnic Cohort. Cancer Epidemiol. 2020 04; 65:101685.
    View in: PubMed
    Score: 0.289
  3. Loo LWM, Williams M, Hernandez BY. The high and heterogeneous burden of breast cancer in Hawaii: A unique multiethnic U.S. Population. Cancer Epidemiol. 2019 02; 58:71-76.
    View in: PubMed
    Score: 0.266
  4. Maskarinec G, Ju D, Horio D, Loo LW, Hernandez BY. Involution of breast tissue and mammographic density. Breast Cancer Res. 2016 12 15; 18(1):128.
    View in: PubMed
    Score: 0.232
  5. Hernandez BY, Wilkens LR, Le Marchand L, Horio D, Chong CD, Loo LW. Differences in IGF-axis protein expression and survival among multiethnic breast cancer patients. Cancer Med. 2015 Mar; 4(3):354-62.
    View in: PubMed
    Score: 0.204
  6. Debeljak M, Cho S, Downs BM, Considine M, Avin-McKelvey B, Wang Y, Perez PN, Grizzle WE, Hoadley KA, Lynch CF, Hernandez BY, van Diest PJ, Cozen W, Hamilton AS, Hawes D, Gabrielson E, Cimino-Mathews A, Florea LD, Cope L, Umbricht CB. Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ. Breast Cancer Res. 2024 Dec 04; 26(1):178.
    View in: PubMed
    Score: 0.101
  7. Abe JV, Legaspi J, Guillermo C, Bogumil D, Setiawan VW, Le Marchand L, Hernandez BY, Wilkens LR, Maskarinec G. Breast, Colorectal, and Prostate Cancer Incidence among Filipino Americans by Generational Status in the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev. 2024 Oct 02; 33(10):1311-1317.
    View in: PubMed
    Score: 0.100
  8. Sanchez P, Van Dyke AL, Petkov VI, Yuan Y, Bonds S, Valenzuela C, Tuan AW, Moravec R, Altekruse SF, Singhi AD, Serdy KM, Wu Y, Cress RD, Doherty JA, Mueller L, Hernandez BY, Lynch CF, Tucker TC, Wu XC, Matrisian L, Penberthy L. NCI SEER-Linked Virtual Tissue Repository Pilot. J Natl Cancer Inst Monogr. 2024 Aug 01; 2024(65):180-190.
    View in: PubMed
    Score: 0.098
  9. Wang Z, Katsaros D, Wang J, Biglio N, Hernandez BY, Fei P, Lu L, Risch H, Yu H. Machine learning-based cluster analysis of immune cell subtypes and breast cancer survival. Sci Rep. 2023 11 03; 13(1):18962.
    View in: PubMed
    Score: 0.093
  10. DeRouen MC, Yang J, Li Y, Franke AA, Tome AN, White KK, Hernandez BY, Shvetsov Y, Setiawan V, Wu AH, Wilkens LR, Le Marchand L, Loo LWM, Cheng I. Circulating 27-hydroxycholesterol, lipids, and steroid hormones in breast cancer risk: a nested case-control study of the Multiethnic Cohort Study. Breast Cancer Res. 2023 08 14; 25(1):95.
    View in: PubMed
    Score: 0.092
  11. Ihenacho U, McKinley MA, Vu A, Hernandez BY, Loo LWM, Gomez SL, Wu AH, Cheng I. Characterizing breast cancer incidence and trends among Asian American, Native Hawaiian, and non-Hispanic White women in Hawai'i, 1990-2014. Cancer Causes Control. 2023 Mar; 34(3):241-249.
    View in: PubMed
    Score: 0.088
  12. Robinson TJ, Wilson LE, Marcom PK, Troester M, Lynch CF, Hernandez BY, Parrilla E, Brauer HA, Dinan MA. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database. JAMA Netw Open. 2021 10 01; 4(10):e2131020.
    View in: PubMed
    Score: 0.081
  13. Loo LWM, Gao C, Shvetsov YB, Okoro DR, Hernandez BY, Bargonetti J. MDM2, MDM2-C, and mutant p53 expression influence breast cancer survival in a multiethnic population. Breast Cancer Res Treat. 2019 Feb; 174(1):257-269.
    View in: PubMed
    Score: 0.066
  14. Shimizu Y, Furuya H, Tamashiro PM, Iino K, Chan OTM, Goodison S, Pagano I, Hokutan K, Peres R, Loo LWM, Hernandez B, Naing A, Chong CDK, Rosser CJ, Kawamori T. Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model. Carcinogenesis. 2018 01 12; 39(1):47-55.
    View in: PubMed
    Score: 0.063
  15. Shen Y, Katsaros D, Loo LW, Hernandez BY, Chong C, Canuto EM, Biglia N, Lu L, Risch H, Chu WM, Yu H. Prognostic and predictive values of long non-coding RNA LINC00472 in breast cancer. Oncotarget. 2015 Apr 20; 6(11):8579-92.
    View in: PubMed
    Score: 0.052
  16. Kim Y, Franke AA, Shvetsov YB, Wilkens LR, Cooney RV, Lurie G, Maskarinec G, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN, Goodman MT. Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study. BMC Cancer. 2014 Jan 17; 14:29.
    View in: PubMed
    Score: 0.047
  17. Ollberding NJ, Kim Y, Shvetsov YB, Wilkens LR, Franke AA, Cooney RV, Maskarinec G, Hernandez BY, Henderson BE, Le Marchand L, Kolonel LN, Goodman MT. Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer. Cancer Prev Res (Phila). 2013 Mar; 6(3):188-95.
    View in: PubMed
    Score: 0.045
  18. Kim Y, Ollberding NJ, Shvetsov YB, Franke AA, Wilkens LR, Maskarinec G, Hernandez BY, Le Marchand L, Henderson BE, Kolonel LN, Goodman MT. Plasma matrix metalloproteinases and postmenopausal breast cancer risk: a nested case-control study in the Multiethnic Cohort study. Breast Cancer Res Treat. 2012 Dec; 136(3):837-45.
    View in: PubMed
    Score: 0.044
  19. Shimizu Y, Luk H, Horio D, Miron P, Griswold M, Iglehart D, Hernandez B, Killeen J, ElShamy WM. BRCA1-IRIS overexpression promotes formation of aggressive breast cancers. PLoS One. 2012; 7(4):e34102.
    View in: PubMed
    Score: 0.042
  20. Verheus M, Maskarinec G, Erber E, Steude JS, Killeen J, Hernandez BY, Cline JM. Mammographic density and epithelial histopathologic markers. BMC Cancer. 2009 Jun 13; 9:182.
    View in: PubMed
    Score: 0.034
  21. Maskarinec G, Erber E, Verheus M, Hernandez BY, Killeen J, Cashin S, Cline JM. Soy consumption and histopathologic markers in breast tissue using tissue microarrays. Nutr Cancer. 2009; 61(5):708-16.
    View in: PubMed
    Score: 0.033
  22. Hernandez BY. Highlights of recent cancer incidence data in Hawaii. Hawaii Med J. 2003 Jan; 62(1):17-8.
    View in: PubMed
    Score: 0.022
  23. Morimoto Y, Killeen J, Hernandez BY, Mark Cline J, Maskarinec G. Parity and expression of epithelial histopathologic markers in breast tissue. Eur J Cancer Prev. 2013 Sep; 22(5):404-8.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support